Otsuka’s ADHD drug centanafadine is currently under review by the US FDA, with a PDUFA date of 24 July 2026.

A long-term study found girls with ADHD especially from disadvantaged backgrounds face a higher risk of multiple chronic ...

Attention Deficit Disorder and ADHD are some of the most common disorders in the world. Estimates are not very precise, but ...

Viloxazine extended-release shows promise for treating adults with ADHD who also experience symptoms of depression and anxiety.

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that the first patient has been ...

Understood reports ADHD, originally known as ADD, is now officially termed attention-deficit hyperactivity disorder, with new ...

Maternal vitamin D concentrations during pregnancy could influence the risk for ASD and ADHD symptoms in childhood and adolescence.

Longer durations of full breastfeeding are linked to fewer ADHD symptoms in children, suggesting early feeding patterns may ...

Genetic data suggest that expanding diagnostic criteria may account for much of the increase in ADHD and autism diagnoses.

As ADHD diagnoses and self-diagnoses continue to rise, one question remains unexplored: What role does technology play in how ...

Girls with ADHD who grow up in disadvantaged households may be more than twice as likely to develop multiple long-term health conditions as adults, according to a new study.

ATTENTION Deficit Hyperactivity Disorder, otherwise known as ADHD, is a condition we may hear a lot about but not fully ...